Laboratory Corporation of America Holdings

NYSE:LH Stock Report

Mkt Cap: US$19.1b

Laboratory Corporation of America Holdings Future Growth

Future criteria checks 1/6

Laboratory of America Holdings is forecasted to grow earnings and revenue by 9.8% and 3.6% per annum respectively. EPS is expected to grow by 9.3%. Return on equity is forecast to be 15% in 3 years.

Key information

9.8%

Earnings growth rate

9.3%

EPS growth rate

Healthcare earnings growth13.3%
Revenue growth rate3.6%
Future return on equity15.0%
Analyst coverage

Good

Last updated19 May 2023

Recent future growth updates

Is It Too Late To Consider Buying Laboratory Corporation of America Holdings (NYSE:LH)?

May 26
Is It Too Late To Consider Buying Laboratory Corporation of America Holdings (NYSE:LH)?

Laboratory Corporation of America Holdings (NYSE:LH) Shares Could Be 32% Below Their Intrinsic Value Estimate

Mar 02
Laboratory Corporation of America Holdings (NYSE:LH) Shares Could Be 32% Below Their Intrinsic Value Estimate

Recent updates

Is It Too Late To Consider Buying Laboratory Corporation of America Holdings (NYSE:LH)?

May 26
Is It Too Late To Consider Buying Laboratory Corporation of America Holdings (NYSE:LH)?

Laboratory Corporation of America Holdings' (NYSE:LH) Returns On Capital Are Heading Higher

Mar 16
Laboratory Corporation of America Holdings' (NYSE:LH) Returns On Capital Are Heading Higher

Laboratory Corporation of America Holdings (NYSE:LH) Shares Could Be 32% Below Their Intrinsic Value Estimate

Mar 02
Laboratory Corporation of America Holdings (NYSE:LH) Shares Could Be 32% Below Their Intrinsic Value Estimate

Laboratory Corporation of America Non-GAAP EPS of $4.14 in-line, revenue of $3.7B misses by $40M, introduces FY23 outlook

Feb 16

At US$254, Is It Time To Put Laboratory Corporation of America Holdings (NYSE:LH) On Your Watch List?

Jan 30
At US$254, Is It Time To Put Laboratory Corporation of America Holdings (NYSE:LH) On Your Watch List?

Laboratory Corporation: Plenty Of Growth Runway

Jan 19

Here's Why Laboratory Corporation of America Holdings (NYSE:LH) Can Manage Its Debt Responsibly

Jan 16
Here's Why Laboratory Corporation of America Holdings (NYSE:LH) Can Manage Its Debt Responsibly

Laboratory Corporation of America declares $0.72 dividend

Jan 12

Returns At Laboratory Corporation of America Holdings (NYSE:LH) Are On The Way Up

Dec 07
Returns At Laboratory Corporation of America Holdings (NYSE:LH) Are On The Way Up

Is There An Opportunity With Laboratory Corporation of America Holdings' (NYSE:LH) 25% Undervaluation?

Nov 24
Is There An Opportunity With Laboratory Corporation of America Holdings' (NYSE:LH) 25% Undervaluation?

Laboratory Corporation: Buy Rating Holds Following Solid Mid-Level Growth

Nov 08

Laboratory Corporation of America Q3 2022 Earnings Preview

Oct 26

We Think Laboratory Corporation of America Holdings (NYSE:LH) Can Stay On Top Of Its Debt

Oct 14
We Think Laboratory Corporation of America Holdings (NYSE:LH) Can Stay On Top Of Its Debt

Laboratory Corporation of America declares $0.72 dividend

Oct 12

Is Laboratory Corporation of America Holdings (NYSE:LH) Potentially Undervalued?

Sep 28
Is Laboratory Corporation of America Holdings (NYSE:LH) Potentially Undervalued?

LabCorp to pay $273M to company for infringing prenatal test patents - Bloomberg

Sep 23

LabCorp: Drug Development Segment Spinoff Poised To Generate Significant Value

Aug 23

Returns On Capital Are Showing Encouraging Signs At Laboratory Corporation of America Holdings (NYSE:LH)

Aug 22
Returns On Capital Are Showing Encouraging Signs At Laboratory Corporation of America Holdings (NYSE:LH)

Laboratory Corp: The Force Is Strong With This One

Aug 17

Labcorp plans to spinoff clinical drug trials and development business - WSJ

Jul 28

Labcorp expands automated clinical trial kit production line at Belgium facility

Jul 18

Laboratory Corporation of America Holdings (NYSE:LH) Has A Pretty Healthy Balance Sheet

Jul 15
Laboratory Corporation of America Holdings (NYSE:LH) Has A Pretty Healthy Balance Sheet

Labcorp to partner with a Spanish cancer research center for oncology clinical trials

Jul 11

Is Now An Opportune Moment To Examine Laboratory Corporation of America Holdings (NYSE:LH)?

Jun 30
Is Now An Opportune Moment To Examine Laboratory Corporation of America Holdings (NYSE:LH)?

Laboratory Corp: 15% Reward Asymmetry Under-Reflected, Seeking Exit At $280 Per Share

Jun 05

Returns On Capital Are Showing Encouraging Signs At Laboratory Corporation of America Holdings (NYSE:LH)

May 16
Returns On Capital Are Showing Encouraging Signs At Laboratory Corporation of America Holdings (NYSE:LH)

Laboratory Corporation of America Holdings (NYSE:LH) Shares Could Be 49% Below Their Intrinsic Value Estimate

Apr 11
Laboratory Corporation of America Holdings (NYSE:LH) Shares Could Be 49% Below Their Intrinsic Value Estimate

What Is Laboratory Corporation of America Holdings's (NYSE:LH) Share Price Doing?

Mar 30
What Is Laboratory Corporation of America Holdings's (NYSE:LH) Share Price Doing?

Laboratory Corporation Of America: An Undervalued Play In The Life Sciences Space

Mar 20

Should You Be Adding Laboratory Corporation of America Holdings (NYSE:LH) To Your Watchlist Today?

Mar 18
Should You Be Adding Laboratory Corporation of America Holdings (NYSE:LH) To Your Watchlist Today?

Laboratory Corporation of America Holdings (NYSE:LH) Seems To Use Debt Quite Sensibly

Mar 06
Laboratory Corporation of America Holdings (NYSE:LH) Seems To Use Debt Quite Sensibly

Returns on Capital Paint A Bright Future For Laboratory Corporation of America Holdings (NYSE:LH)

Feb 06
Returns on Capital Paint A Bright Future For Laboratory Corporation of America Holdings (NYSE:LH)

Are Investors Undervaluing Laboratory Corporation of America Holdings (NYSE:LH) By 37%?

Jan 11
Are Investors Undervaluing Laboratory Corporation of America Holdings (NYSE:LH) By 37%?

Is It Time To Consider Buying Laboratory Corporation of America Holdings (NYSE:LH)?

Dec 30
Is It Time To Consider Buying Laboratory Corporation of America Holdings (NYSE:LH)?

Here's Why We Think Laboratory Corporation of America Holdings (NYSE:LH) Is Well Worth Watching

Dec 17
Here's Why We Think Laboratory Corporation of America Holdings (NYSE:LH) Is Well Worth Watching

Is Laboratory Corporation of America Holdings (NYSE:LH) Using Too Much Debt?

Dec 05
Is Laboratory Corporation of America Holdings (NYSE:LH) Using Too Much Debt?

Investors Shouldn't Overlook Laboratory Corporation of America Holdings' (NYSE:LH) Impressive Returns On Capital

Oct 30
Investors Shouldn't Overlook Laboratory Corporation of America Holdings' (NYSE:LH) Impressive Returns On Capital

Why Laboratory Corporation of America Holdings (NYSE:LH) Could Be Worth Watching

Sep 22
Why Laboratory Corporation of America Holdings (NYSE:LH) Could Be Worth Watching

Here's Why I Think Laboratory Corporation of America Holdings (NYSE:LH) Is An Interesting Stock

Sep 09
Here's Why I Think Laboratory Corporation of America Holdings (NYSE:LH) Is An Interesting Stock

Laboratory Corporation of America Holdings (NYSE:LH) Seems To Use Debt Rather Sparingly

Aug 27
Laboratory Corporation of America Holdings (NYSE:LH) Seems To Use Debt Rather Sparingly

Labcorp Is Up 61% And Looks Set For More Growth

Aug 18

Earnings and Revenue Growth Forecasts

NYSE:LH - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202516,4501,5071,7442,3149
12/31/202415,8921,3441,5072,06115
12/31/202315,2241,1901,2151,74215
3/31/202011,5873211,0701,483N/A
12/31/201911,5558241,0451,445N/A
9/30/201911,3897559671,361N/A
6/30/201911,2928537581,158N/A
3/31/201911,2768968901,292N/A
12/31/201811,3338849261,305N/A
9/30/201811,2911,4141,0301,384N/A
6/30/201811,0811,2661,1981,529N/A
3/31/201810,7431,2171,1371,452N/A
12/31/201710,3081,2271,1831,498N/A
9/30/20179,9517241,0891,382N/A
6/30/20179,7027329511,235N/A
3/31/20179,5567519931,274N/A
12/31/20169,553712N/A1,197N/A
9/30/20169,295658N/A1,112N/A
6/30/20169,192633N/A1,150N/A
3/31/20169,029599N/A1,197N/A
12/31/20158,506438N/A982N/A
9/30/20157,774447N/A812N/A
6/30/20157,056430N/A699N/A
3/31/20156,353401N/A510N/A
12/31/20146,012511N/A739N/A
9/30/20145,936518N/A774N/A
6/30/20145,846529N/A833N/A
3/31/20145,798540N/A763N/A
12/31/20135,808574N/A819N/A
9/30/20135,777568N/A824N/A
6/30/20135,734567N/A794N/A
3/31/20135,689569N/A843N/A
12/31/20125,671583N/A841N/A
9/30/20125,632598N/A866N/A
6/30/20125,617585N/A839N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: LH's forecast earnings growth (9.8% per year) is above the savings rate (2.1%).

Earnings vs Market: LH's earnings (9.8% per year) are forecast to grow slower than the US market (15.5% per year).

High Growth Earnings: LH's earnings are forecast to grow, but not significantly.

Revenue vs Market: LH's revenue (3.6% per year) is forecast to grow slower than the US market (7.9% per year).

High Growth Revenue: LH's revenue (3.6% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: LH's Return on Equity is forecast to be low in 3 years time (15%).


Discover growth companies